[1] XIE S M. Pay attention to dermatopharmacokinetics in investigation on the topical dermatological drugs [J]. Chin J Clin Pharmacol( 中国临床 药理学杂志 ), 2007, 23 (4):313-315.
[2] XIE S M, YANG J B, LIU L F. Point on consideration of the clinical trial design and evaluation on the skin external antimicrobial drugs[J]. Chin J Clin Pharmacol( 中国临床 药理学杂志 ),2006, 22 (5):374-377.
[3] HERKENNE C, ALBERTI I, NAIK A, et al. In vivo methods for the assessment of topical drug bioavilability[J]. Pharm Res, 2008, 25 (1):87-103.
[4] PANCHAGNULA R, RITSCHEL W A. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies [J]. J Pharm Pharmacol , 1991, 43 (9):609-614.
[5] N'DRI-STEMPFER B, NAVIDI W C, GUY R H, et al. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics[J]. Pharm Res , 2009,26 (2):316-328.
[6] ESCOBAR-CHAVEZ J J, MERINO-SANJUAN V, LOPEZ- CERVANTES M, et al. The tape-stripping technique as a method for drug quantification in skin[J]. J Pharm Pharmaceut Sci , 2008,11
(1):104-130.
[7] NAVIDI W, HUTCHINSON A, N'DRI-STEMPFER B, et al. Determining bioequivalence of topical dermatological drug products by tape-stripping[J]. J Pharmacokinet Pharmacodyn, 2008, 35 (3):337-348.
[8] PERSHING L K, CORLETT J L, NELSON J L. Comparison of dermatopharmacokinetic <>vs clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans [J]. Pharm Res, 2002, 19 (3):270-277.
[9] LODéN M, AKERSTR?M U, LINDAHL K, et al . Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration[J]. Int J Pharm , 2004, 284(1-2):23-30.
[10] PELLANDA C, OTTIKER E, STRUB C, et al. Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency [J]. Arch Dermatol Res, 2006, 298 (5):221-230.
[11] HERKENNE C, NAIK A, KALIA Y N, et al. Dermatopharmacokinetic prediction of topical drug bioavailability in vivo [J]. J Invest Dermatol, 2007, 127 (4):887-894.
[12] WIEDERSBERG S, LEOPOLD C S, GUY R H. Dermatopharmacokinetics of betamethasone 17-valerate: Influence of formulation viscosity and skin surface cleaning procedure [J]. Eur J Pharm Biopharm, 2009,71(2):362-366.
[13] CHAURASIA C S , MüLLER M , BASHAW E D , et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives[J]. Pharm Res , 2007, 24(5):1014-1025.
[14] BENFELDT E, HANSEN S H, V?LUND A, et al. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method[J]. J Invest Dermatol, 2007, 127 (1):170-178.
[15] MATHY F X, LOMBRY C, VERBEECK R K, et al. Study of the percutaneous penetration of flurbiprofen by cutaneous and subcutaneous microdialysis after iontophoretic delivery in rat[J]. J Pharm Sci, 2005, 94 (1):144-152.
[16] TREFFEL P, MAKKI S, FAIVRE B, et al. Citropten and bergapten suction blister fluid concentrations after solar product application in man [J]. Skin Pharmacol, 1991, 4 (2):100-108.
[17] SVEDMAN P, SVEDMAN C. Skin mini-erosion sampling technique: feasibility study with regard to serial glucose measurement [J]. Pharm Res, 1998, 15 (6):883-888.
[18] SCHROLNBERGER C, BRUNNER M, MAYER B X, et al. Application of the minimal trauma tissue biopsy to transdermal clinical pharmacokinetic studies [J]. J Controlled Release, 2001, 75 (3):297-306.
[19] CASPERS P J, LUCASSEN G W, CARTER E A, et al. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles [J]. J Invest Dermatol, 2001, 116 (3):434-442.
[20] CROWTHER J M , SIEG A , BLENKIRON P , et al. Measuring the effects of topical moisturizers on changes in stratum corneum thickness, water gradients and hydration in vivo [J]. Br J Dermatol , 2008, 159(3):567-577.
[21] WASCOTTE V, CASPERS P, DE STERKE J, et al. Assessment of the “skin reservoir” of urea by confocal Raman microspectroscopy and reverse iontophoresis in vivo[J]. Pharm Res, 2007, 24(10):1897-1901.
[22] DARWIN M , SCHANZER S , TEICHMANN A , et al. Functional food and bioavailability in the target organ skin [J]. Hautarzt , 2006, 57(4):286, 288-290.
[23] GOTTER B , FAUBEL W , NEUBERT R H . Optical methods for measurements of skin penetration [J]. Skin Pharmacol Physiol , 2008, 21(3):156-165.